Search This Blog

Thursday, August 07, 2014

INTRAOCULAR (IOP) PRESSURE INCREASE IN BEVACIZUMAB INJECTIONS

OP increases with intravitreal bevacizumab injection, reaching 50 mmHg or more in about one third of patients. A higher IOP is expected if no subconjunctival reflux occurs. The baseline IOP does not influence the incidence of subconjunctival reflux. The clinical relevance of these facts has yet to be clarified.